TD Cowen Issues Positive Forecast for HCA Healthcare (NYSE:HCA) Stock Price

HCA Healthcare (NYSE:HCA) had its target price boosted by TD Cowen from $380.00 to $490.00 in a research report released on Monday morning,Benzinga reports. TD Cowen currently has a buy rating on the stock.

Several other analysts also recently commented on the company. JPMorgan Chase & Co. raised their target price on HCA Healthcare from $360.00 to $370.00 and gave the company a “neutral” rating in a research note on Monday, August 4th. Mizuho raised their target price on HCA Healthcare from $475.00 to $505.00 and gave the company an “outperform” rating in a research note on Monday. Oppenheimer raised their target price on HCA Healthcare from $400.00 to $500.00 and gave the company an “outperform” rating in a research note on Monday. UBS Group raised their target price on HCA Healthcare from $495.00 to $525.00 and gave the company a “buy” rating in a research note on Monday. Finally, Cantor Fitzgerald reiterated an “overweight” rating on shares of HCA Healthcare in a research note on Monday. Thirteen investment analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. According to data from MarketBeat, HCA Healthcare presently has a consensus rating of “Moderate Buy” and an average price target of $471.42.

HCA Healthcare Trading Up 4.8%

HCA stock opened at $468.68 on Monday. The stock has a 50-day moving average price of $416.33 and a 200-day moving average price of $383.23. HCA Healthcare has a 1-year low of $289.98 and a 1-year high of $469.18. The firm has a market cap of $109.67 billion, a PE ratio of 18.12, a price-to-earnings-growth ratio of 1.41 and a beta of 1.40.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, topping the consensus estimate of $5.64 by $1.32. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The firm had revenue of $19.16 billion during the quarter, compared to analyst estimates of $18.55 billion. During the same period last year, the company posted $4.90 EPS. The business’s quarterly revenue was up 9.6% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, analysts forecast that HCA Healthcare will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, December 29th. Shareholders of record on Monday, December 15th will be given a dividend of $0.72 per share. The ex-dividend date of this dividend is Monday, December 15th. This represents a $2.88 annualized dividend and a dividend yield of 0.6%. HCA Healthcare’s dividend payout ratio (DPR) is currently 11.13%.

Insider Activity at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of HCA Healthcare stock in a transaction that occurred on Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the transaction, the executive vice president owned 31,503 shares of the company’s stock, valued at $13,194,716.52. This trade represents a 10.85% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 1.30% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On HCA Healthcare

Hedge funds have recently modified their holdings of the stock. Park Place Capital Corp raised its holdings in shares of HCA Healthcare by 2,336.0% in the 2nd quarter. Park Place Capital Corp now owns 1,218 shares of the company’s stock worth $474,000 after purchasing an additional 1,168 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of HCA Healthcare by 11.9% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,454 shares of the company’s stock worth $8,796,000 after purchasing an additional 2,698 shares during the period. Harrell Investment Partners LLC raised its holdings in shares of HCA Healthcare by 176.3% in the 2nd quarter. Harrell Investment Partners LLC now owns 1,815 shares of the company’s stock worth $695,000 after purchasing an additional 1,158 shares during the period. Brown Advisory Inc. raised its holdings in shares of HCA Healthcare by 53.9% in the 1st quarter. Brown Advisory Inc. now owns 4,630 shares of the company’s stock worth $1,600,000 after purchasing an additional 1,622 shares during the period. Finally, Simplicity Wealth LLC raised its holdings in HCA Healthcare by 92.7% during the 2nd quarter. Simplicity Wealth LLC now owns 1,798 shares of the company’s stock valued at $689,000 after acquiring an additional 865 shares during the period. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.